CLINICAL TRIALS PROFILE FOR JENTADUETO
✉ Email this page to a colleague
All Clinical Trials for JENTADUETO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01947153 ↗ | Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®. | Completed | Boehringer Ingelheim | Phase 1 | 2013-11-01 | The objective of the current study is to demonstrate bioequivalence of two 2.5 mg linagliptin/500 mg metformin fixed dose combination tablets compared to the free combination of the linagliptin 5 mg and metformin 1000 mg in healthy male and female volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for JENTADUETO
Condition Name
Clinical Trial Locations for JENTADUETO
Clinical Trial Progress for JENTADUETO
Clinical Trial Phase
Clinical Trial Sponsors for JENTADUETO
Sponsor Name